RESMED INC Research And Development Expense

• RESMED INC showed an increase of +7.7% in Research And Development Expense from 2024 to 2025.
• This data is from RESMED INC's annual report (Form 10-K), filed with the SEC on August 8, 2025.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2009 to 2025), RESMED INC's Research And Development Expense has grown by 425.4%.
• Historical annual values: Fiscal year 2025: $331.28 million | Fiscal year 2024: $307.53 million | Fiscal year 2023: $287.64 million | Fiscal year 2022: $253.58 million | Fiscal year 2021: $225.28 million | Fiscal year 2020: $201.95 million | Fiscal year 2019: $180.65 million | Fiscal year 2018: $155.15 million | Fiscal year 2017: $144.47 million | Fiscal year 2016: $118.65 million | Fiscal year 2015: $114.87 million | Fiscal year 2014: $118.23 million | Fiscal year 2013: $120.12 million | Fiscal year 2012: $109.73 million | Fiscal year 2011: $92.01 million | Fiscal year 2010: $75.20 million | Fiscal year 2009: $63.06 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026